Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXAGEN INC.XGN · Entity 935 | Director | June 09, 2026 | August 19, 2026 |
| Fulgent Genetics, Inc.FLGT · Entity 2545 | CFO and Treasurer | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXAGEN INC.
Report date June 09, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option(right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.31 · Expires 2036-06-08 | Direct | 46,500 |
Reported balance
After 2026-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 37,500 · Balance 46,500 F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Fulgent Genetics, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 356,543 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Tax withholding · Disposed 2,087 · Balance 356,543 F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2022 Filed May 18, 2022 20:41 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 325 | $53.38 | $17,349.25 |
DisclosureSEC source: 0001209191-22-030070 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,443 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $53.27 to $53.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 03, 2022 Filed May 5, 2022 20:48 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 806 | $56.69 | $45,692.14 |
DisclosureSEC source: 0001209191-22-027378 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,768 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 23:13 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 454 | $56.31 | $25,563.88 |
DisclosureSEC source: 0001209191-22-016456 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,574 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $55.77 to $57.20, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:33 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014769 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,028 F2 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after March 1, 2022, and 1/16th of such shares vesting at the end of every three-month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:33 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014769 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,028 F1 · shares: Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2022, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:15 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 806 | $66.49 | $53,590.94 |
DisclosureSEC source: 0001209191-22-010889 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,028 F2 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:15 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 303 | $66.49 | $20,146.47 |
DisclosureSEC source: 0001209191-22-010889 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,834 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:40 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 806 | $63.15 | $50,898.90 |
DisclosureSEC source: 0001209191-22-007469 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,137 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:27 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-001996 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,943 F1 · shares: Reflects shares transferred as a gift to a donor advised fund (the "Fund"). The Reporting Person disclaims beneficial ownership over the shares held by the Fund. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 21:19 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 620 | $83.16 | $51,557.96 |
DisclosureSEC source: 0001209191-21-068107 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,943 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $82.1000 to $84.1171, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:09 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 10,263 | $95.44 | $979,531.51 |
DisclosureSEC source: 0001209191-21-066399 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,563 F1 · price: The shares were sold in multiple transactions at prices ranging from $95.00 to $95.73, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 18, 2021 Filed Nov 19, 2021 00:44 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 500 | $97.46 | $48,730.50 |
DisclosureSEC source: 0001209191-21-065642 · doc4.xml · nonDerivative · entry 3 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,826 F4 · price: The shares were sold in multiple transactions at prices ranging from $97.1000 to $97.9350, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 00:44 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,214 | $95.50 | $115,939.55 |
DisclosureSEC source: 0001209191-21-065642 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,326 F3 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $95.3400 to $95.6200, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 00:44 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 455 | $95.50 | $43,453.46 |
DisclosureSEC source: 0001209191-21-065642 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,540 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $95.3400 to $95.6200, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:13 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 1,181 | $88.12 | $104,069.72 |
DisclosureSEC source: 0001209191-21-063142 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,995 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020. Read SEC document |
| September 02, 2021 Filed Sep 8, 2021 00:28 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 607 | $94.29 | $57,235.30 |
DisclosureSEC source: 0001209191-21-055088 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,176 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $93.72 to $95.01, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:58 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,682 | $95.12 | $159,996.38 |
DisclosureSEC source: 0001209191-21-052302 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,783 F1 · shares: The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019 and November 1, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $94.6257 to $96.0400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 22:50 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 4,723 | $100.46 | $474,472.58 |
DisclosureSEC source: 0001209191-21-050044 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,465 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 3, 2020. Read SEC document |
| June 04, 2021 Filed Jun 4, 2021 22:38 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 789 | $74.26 | $58,588.30 |
DisclosureSEC source: 0001209191-21-038394 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,188 Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 22:38 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 461 | $71.34 | $32,885.76 |
DisclosureSEC source: 0001209191-21-038394 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,977 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $71.11 to $71.58, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 26, 2021 Filed May 27, 2021 23:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 18,000 | $72.90 | $1,312,119.00 |
DisclosureSEC source: 0001209191-21-036340 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,438 F2 · price: The shares were sold in multiple transactions at prices ranging from $72.0828 to $74.14, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 25, 2021 Filed May 27, 2021 23:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 10,358 | $72.94 | $755,479.37 |
DisclosureSEC source: 0001209191-21-036340 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,438 F1 · price: The shares were sold in multiple transactions at prices ranging from $72.50 to $73.22, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:29 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,155 | $70.71 | $81,670.28 |
DisclosureSEC source: 0001209191-21-034519 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,796 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019 and November 1, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $69.61 to $71.05, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 00:44 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 403 | $111.38 | $44,886.14 |
DisclosureSEC source: 0001209191-21-016504 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,951 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. Read SEC document |
| February 15, 2021 Filed Feb 16, 2021 23:05 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 1,109 | $161.09 | $178,648.81 |
DisclosureSEC source: 0001209191-21-010920 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,354 F1 · shares: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019 and November 1, 2019. Read SEC document |
| December 21, 2020 Filed Feb 16, 2021 23:05 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010920 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,463 Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 23:26 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 16,958 | $51.94 | $880,734.08 |
DisclosureSEC source: 0001209191-20-063037 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,563 F2 · price: The shares were sold in multiple transactions at prices ranging from $51.1481 to $53.0501, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 09, 2020 Filed Dec 11, 2020 23:26 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 10,662 | $51.60 | $550,189.05 |
DisclosureSEC source: 0001209191-20-063037 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,521 F1 · price: The shares were sold in multiple transactions at prices ranging from $51.5304 to $51.8381, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:06 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 29,319 | $46.62 | $1,366,728.64 |
DisclosureSEC source: 0001209191-20-061786 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,183 F3 · price: The shares were sold in multiple transactions at prices ranging from $46.07 to $46.84, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:06 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 630 | $45.09 | $28,404.50 |
DisclosureSEC source: 0001209191-20-061786 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,502 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $44.51 to $45.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 00:52 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 3,326 | $45.45 | $151,162.71 |
DisclosureSEC source: 0001209191-20-059270 · doc4.xml · nonDerivative · entry 3 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,132 F4 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on November 1, 2019. F5 · price: The shares were sold in multiple transactions at prices ranging from $45.2512 to $45.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 00:52 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 441 | $45.45 | $20,042.92 |
DisclosureSEC source: 0001209191-20-059270 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,458 F2 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019. F3 · price: The shares were sold in multiple transactions at prices ranging from $45.2512 to $45.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:52 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 100,000 | $46.17 | $4,616,980.00 |
DisclosureSEC source: 0001209191-20-059270 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,899 F1 · price: On November 16, 2020, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, the reporting person sold 100,000 shares in multiple transactions at prices ranging from $43.08 to $48.70, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 00:45 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 425 | $28.32 | $12,034.56 |
DisclosureSEC source: 0001209191-20-049574 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,899 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $27.57 to $28.59, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 01:14 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 25,407 | $44.16 | $1,122,039.18 |
DisclosureSEC source: 0001209191-20-047661 · doc4.xml · nonDerivative · entry 4 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,774 F5 · price: The shares were sold in multiple transactions at prices ranging from $44.05 to $45.02, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 17, 2020 Filed Aug 20, 2020 01:14 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 9,928 | $43.55 | $432,405.10 |
DisclosureSEC source: 0001209191-20-047661 · doc4.xml · nonDerivative · entry 3 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361,181 F4 · price: The shares were sold in multiple transactions at prices ranging from $43.50 to $43.64, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 17, 2020 Filed Aug 20, 2020 01:14 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 100,000 | $41.47 | $4,146,920.00 |
DisclosureSEC source: 0001209191-20-047661 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,109 F3 · price: On August 17, 2020, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, the reporting person sold 100,000 shares in multiple transactions at prices ranging from $40.59 to $43.06, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 17, 2020 Filed Aug 20, 2020 01:14 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,308 | $41.11 | $53,771.62 |
DisclosureSEC source: 0001209191-20-047661 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,109 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 1, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $41.10 to $41.11, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:28 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,396 | $42.06 | $58,711.71 |
DisclosureSEC source: 0001209191-20-046366 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,417 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. F2 · price: The shares were sold in multiple transactions at prices ranging from $40.36 to $42.76, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 03, 2020 Filed Aug 6, 2020 00:54 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045392 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,813 F1 · shares: Reflects an award of restricted stock units relating to 40,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 15, 2020, and 1/16th of such shares vesting every three months over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. Read SEC document |
| June 02, 2020 Filed Jun 3, 2020 21:14 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 425 | $18.06 | $7,673.80 |
DisclosureSEC source: 0001209191-20-034125 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,813 F1 · kind: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. F2 · price: The shares were sold in multiple transactions at prices ranging from $17.50 to $18.15, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 12, 2020 Filed May 13, 2020 23:13 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,421 | $16.31 | $23,176.08 |
DisclosureSEC source: 0001209191-20-028989 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 434,238 F1 · kind: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. F2 · price: The shares were sold in multiple transactions at prices ranging from $16.26 to $16.34, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 22:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 1,612 | $14.84 | $23,922.08 |
DisclosureSEC source: 0001209191-20-015390 · doc4.xml · nonDerivative · entry 3 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 435,659 F3 · kind: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019. Read SEC document |
| February 25, 2020 Filed Mar 3, 2020 22:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GiftCommon Stock | 1,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015390 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437,271 F2 · price: Bona Fide Gift. No compensation was given to the donor for the gifting of shares. Read SEC document |
| February 10, 2020 Filed Mar 3, 2020 22:07 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon Stock | 1,325 | $16.84 | $22,313.00 |
DisclosureSEC source: 0001209191-20-015390 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438,571 F1 · kind: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 02:22 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | Tax withholdingCommon stock | 1,326 | $15.82 | $20,977.32 |
DisclosureSEC source: 0001209191-19-056235 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,896 F1 · kind: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 21:02 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055161 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 441,222 F1 · shares: Reflects an award of restricted stock units relating to 40,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after December 1, 2019, and 1/16th of such shares vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Kim's continued service for Issuer on each vesting date. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 22:27 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 11,028 | $11.52 | $127,010.58 |
DisclosureSEC source: 0001209191-19-045992 · doc4.xml · nonDerivative · entry 2 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401,222 F3 · price: The shares were sold in multiple transactions at prices ranging from $11.27 to $12.15. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 22:27 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | SaleCommon Stock | 1,361 | $11.34 | $15,437.69 |
DisclosureSEC source: 0001209191-19-045992 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,250 F1 · kind: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016. F2 · price: The shares were sold in multiple transactions at prices ranging from $11.31 to $11.36. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 13:10 UTC | Fulgent Genetics, Inc. FLGT · Entity 2545 | GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-044384 · doc4.xml · nonDerivative · entry 1 KIM PAUL · CIK 0001253820 · CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,611 F1 · shares: Reflects an award of restricted stock units relating to 15,000 shares of the Issuer's common stock. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after August 1, 2019, and 1/16th of the remaining shares vesting at the end of every three-month period over the remaining 36 months, subject to Mr. Kim's continued service for Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.